Arcellx, Inc. advances anito-cel CAR-T therapy for relapsed/refractory multiple myeloma. Click for ACLX pivotal trials, FDA ...

Organizations that treat data integration as a strategic business imperative, not just a technical challenge, will be the brands that win.

IntuigenceAI raises $10 million to launch AI “synthetic engineers” that outperform humans on key tests, backed by Eric ...